|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.20 BRL | +27.02% |
|
-1.45% | +36.91% |
| Mar. 30 | Natura Cosméticos S.A. Announces Board and Committee Changes | CI |
| Mar. 30 | Brazil's Natura announces stake purchase by Advent as founders exit board | RE |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 40.16B | 36.35B | 26.74B | 24.09B | 21.82B | |||||
Total Revenues | 40.16B | 36.35B | 26.74B | 24.09B | 21.82B | |||||
Cost of Goods Sold, Total | 14.01B | 13.16B | 9.68B | 8.37B | 7.29B | |||||
Gross Profit | 26.15B | 23.19B | 17.06B | 15.72B | 14.54B | |||||
Selling General & Admin Expenses, Total | 23.97B | 22.1B | 15.24B | 13.34B | 11.71B | |||||
Provision for Bad Debts | 838M | 606M | 606M | 480M | 545M | |||||
Other Operating Expenses | -272M | 26.09M | -203M | 44.78M | 501M | |||||
Other Operating Expenses, Total | 24.53B | 22.73B | 15.64B | 13.87B | 12.76B | |||||
Operating Income | 1.62B | 460M | 1.42B | 1.85B | 1.78B | |||||
Interest Expense, Total | -845M | -945M | -2.43B | -589M | -578M | |||||
Interest And Investment Income | 265M | 537M | 977M | 341M | 132M | |||||
Net Interest Expenses | -580M | -408M | -1.45B | -247M | -445M | |||||
Currency Exchange Gains (Loss) | 681M | 92.41M | -349M | 204M | -501M | |||||
Other Non Operating Income (Expenses) | -1.06B | -1.32B | -523M | -330M | 96.82M | |||||
EBT, Excl. Unusual Items | 657M | -1.17B | -904M | 1.48B | 932M | |||||
Restructuring Charges | -511M | -659M | -823M | -484M | -76.14M | |||||
Merger & Related Restructuring Charges | - | - | - | - | -375M | |||||
Impairment of Goodwill | - | -283M | -664M | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | 28.11M | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | 34.91M | 43.98M | |||||
Asset Writedown | -6.63M | -97.73M | -54.74M | -47.95M | -23.41M | |||||
Insurance Settlements | - | - | - | - | 44.36M | |||||
Legal Settlements | -21.78M | 40.16M | -105M | -24.93M | 21.17M | |||||
Other Unusual Items | -26.53M | -188M | -118M | -768M | -17.81M | |||||
EBT, Incl. Unusual Items | 91.25M | -2.36B | -2.67B | 215M | 549M | |||||
Income Tax Expense | -1.05B | 120M | -86.4M | 957M | 20.07M | |||||
Earnings From Continuing Operations | 1.14B | -2.48B | -2.58B | -742M | 529M | |||||
Earnings Of Discontinued Operations | -98.55M | -380M | 5.56B | -8.19B | -2.31B | |||||
Net Income to Company | 1.04B | -2.86B | 2.97B | -8.93B | -1.79B | |||||
Minority Interest | 7.27M | -1M | -779K | -179K | - | |||||
Net Income - (IS) | 1.05B | -2.86B | 2.97B | -8.93B | -1.79B | |||||
Net Income to Common Incl Extra Items | 1.05B | -2.86B | 2.97B | -8.93B | -1.79B | |||||
Net Income to Common Excl. Extra Items | 1.15B | -2.48B | -2.58B | -742M | 529M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.76 | -2.08 | 2.16 | -6.46 | -0.88 | |||||
Basic EPS - Continuing Operations | 0.83 | -1.81 | -1.87 | -0.54 | 0.26 | |||||
Basic Weighted Average Shares Outstanding | 1.38B | 1.37B | 1.38B | 1.38B | 2.02B | |||||
Net EPS - Diluted | 0.75 | -2.08 | 2.16 | -6.46 | -0.88 | |||||
Diluted EPS - Continuing Operations | 0.82 | -1.81 | -1.87 | -0.54 | 0.26 | |||||
Diluted Weighted Average Shares Outstanding | 1.4B | 1.37B | 1.38B | 1.38B | 2.02B | |||||
Normalized Basic EPS | 0.3 | -0.53 | -0.41 | 0.67 | 0.29 | |||||
Normalized Diluted EPS | 0.3 | -0.53 | -0.41 | 0.67 | 0.29 | |||||
Dividend Per Share | 0.13 | - | 0.71 | - | - | |||||
Payout Ratio | - | -6.31 | - | -11.45 | -8.11 | |||||
American Depositary Receipts Ratio (ADR) | 2 | 2 | 2 | 2 | 2 | |||||
Supplemental Items | ||||||||||
EBITDA | 2.72B | 1.43B | 1.59B | 2.3B | 2.11B | |||||
EBITA | 1.97B | 764M | 1.72B | 1.99B | 1.86B | |||||
EBIT | 1.62B | 460M | 1.42B | 1.85B | 1.78B | |||||
EBITDAR | 2.9B | 1.62B | 1.63B | 2.31B | 2.12B | |||||
Effective Tax Rate - (Ratio) | -1.15K | -5.07 | 3.24 | 444.75 | 3.66 | |||||
Total Current Taxes | 923M | 718M | 976M | 300M | 363M | |||||
Total Deferred Taxes | -1.97B | -598M | -1.06B | 658M | -343M | |||||
Normalized Net Income | 418M | -733M | -566M | 923M | 582M | |||||
Interest on Long-Term Debt | 211M | 200M | 110M | 88.05M | 109M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 17B | 15.51B | 11.02B | 9.97B | 8.61B | |||||
General and Administrative Expenses | 6.96B | 6.59B | 4.22B | 3.37B | 3.1B | |||||
Research And Development Expense From Footnotes | 544M | 546M | 440M | 197M | 214M | |||||
Net Rental Expense, Total | 182M | 183M | 33.17M | 4.2M | 7.16M | |||||
Imputed Operating Lease Interest Expense | 72.53M | 83.41M | 53.43M | 2.63M | 6.73M | |||||
Imputed Operating Lease Depreciation | 110M | 99.37M | -20.26M | 1.58M | 436K | |||||
Stock-Based Comp., G&A Exp. (Total) | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 276M | 258M | 127M | 67.8M | 66.96M | |||||
Total Stock-Based Compensation | 276M | 258M | 127M | 67.8M | 66.96M |
- Stock Market
- Equities
- NATU3 Stock
- Financials Natura Cosméticos S.A.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















